Printer Friendly

Browse Ranibizumab topic

Dosage and administration subtopic

Articles

1-15 out of 15 article(s)
Title Author Type Date Words
Direct Treatment Costs of Neovascular Age-related Macular Degeneration and Comparison of Gained and/or Preserved Vision with Expenditure. Yildirim, Seyda; Akkin, Cezmi; Oztas, Zafer; Nalcaci, Serhad; Afrashi, Filiz; Mentes, Jale Report Jan 1, 2018 5124
All Types of Age-related Macular Degeneration in One Patient. Cebeci, Zafer; Kir, Nur Case study Nov 1, 2017 1589
Choroidal osteoma and secondary choroidal neovascularization treated with ranibizumab. Sezenoz, Almila Sarigul; Bayar, Sezin Akca; Yilmaz, Gursel Case study Jul 1, 2017 1933
Factors affecting compliance to intravitreal anti-vascular endothelial growth factor therapy in patients with age-related macular degeneration. Polat, Onur; Inan, Sibel; Ozcan, Serkan; Dogan, Mustafa; Kusbeci, Tuncay; Yavas, Guliz Fatma; Inan, Report Jul 1, 2017 4714
Multiple intravitreal ranibizumab injections for persistant choroidal neovascularization associated with presumed ocular histoplasmosis syndrome. Yilmaz, Turgut; Dikci, Seyhan; Genc, Oguzhan; Mutlu, Kayhan Case study Mar 1, 2017 2000
Comparison of Progression Rate of Retinal Pigment Epithelium Loss in Patients with Neovascular Age-Related Macular Degeneration Treated with Ranibizumab and Aflibercept. Wons, Juliana; Wirth, Magdalena A.; Graf, Nicole; Becker, Matthias D.; Michels, Stephan Report Jan 1, 2017 4504
Recurrence of Retinopathy of Prematurity in Zone II Stage 3+ after Ranibizumab Treatment: A Retrospective Study. Hu, Qinrui; Bai, Yujing; Chen, Xiaoli; Huang, Lvzhen; Chen, Yi; Li, Xiaoxin Report Jan 1, 2017 3305
Asymmetric Outcomes of Type 1 Retinopathy of Prematurity after Bilateral Intravitreal Ranibizumab Treatment. Huang, Qiujing; Zhang, Qi; Xu, Yu; Ji, Xunda; Fei, Ping; Peng, Jie; Li, Yi- an; Zhao, Peiquan Report Jan 1, 2017 4183
Clinical efficacy of intravitreal ranibizumab in early and mid-idiopathic choroidal neovascularization. Fan, Chuanfeng; Ji, Qiang; Wang, Yu; Shu, Xiangwen; Xie, Juan Report Jan 1, 2014 2663
A 2-year, phase IV, multicentre, observational study of Ranibizumab 0.5 mg in patients with neovascular age-related macular degeneration in routine clinical practice: The EPICOHORT study. Pagliarini, Sergio; Beatty, Stephen; Lipkova, Blandina; Garcia, Eduardo Perez-Salvador; Reynders, St Report Jan 1, 2014 6759
The anti-VEGF dilemma. Withers, Nikki May 17, 2013 1341
NICE recommends use of Lucentis for NHS treatment of vision loss. Mar 1, 2013 359
Early results of ranibizumab monotherapy in patients with choroidal neovascularization/Koroid neovaskularizasyonunda ranibizumab monoterapisinin erken donem sonuclari. Kocak, Nilufer; Kaya, Mahmut; Selver, Ozlem Barut; Ayhan, Ziya; Kaynak, Suleyman Report Jan 1, 2011 2879
Seeing hope for aging eyes: new research and treatments show promise in halting macular degeneration and restoring vision lost to this age-related eye disorder. Nov 1, 2006 859
Don't lose sight: macular degeneration can rob you of your vision, but a newly approved drug could help preserve--and even improve--your sight. Oct 1, 2006 874

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |